{"nct_id":"NCT05498155","title":"Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2022-11-07","start_date_type":"ACTUAL","primary_completion_date":"2024-11-20","primary_completion_date_type":"ACTUAL","completion_date":"2026-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}